- With the opioid crisis in full force and doctors feeling pressure to cut back on the number of opioid painkillers they prescribe, chronic-pain patients aren't left with many alternatives that are as effective or accessible.
- So the pharmaceutical industry is looking to bring more non-opioid pain medications into market, with 17 drugs in late-stage clinical development and 40 drugs in early-stage development.
- One of the new types of drugs is used to block the nerve-growth factor, which can reduce pain in patients with osteoarthritis, chronic back pain, and cancer pain. The two newsworthy drugs in this category are tanezumab and fasinumab.
- Centrexion, a capsaicin-derived drug, has also received buzz for its pain-reducing properties.
Debbie Page, 66, has suffered from chronic pain for half of her life after a back injury left her with the inability to stand for more than a few minutes at a time.
"After an hour I can't think or see," she said. "The pain takes over and it's torture."
See the rest of the story at Business Insider
NOW WATCH: Why pandas are the most overrated animals on the planet
See Also:
- This is how big the dinosaurs in 'Jurassic World: Fallen Kingdom' are compared to humans
- 23andMe plans to send DNA kits to try to reunite families separated at the border — but privacy issues loom
- A mosquito virus that had never been identified in humans was found in a Florida boy — here's what to know about the Keystone virus
from Feedburner https://ift.tt/2KjUWWq
No comments:
Post a Comment